Jun Matsukawa

Jun Matsukawa

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 4405510
武田薬品工業株式会社
person_outline Jun Matsukawa's MOST POPULAR ARTICLES
1-) The ASK1-MAP kinase cascades in mammalian stress responseJ Matsukawa, A Matsuzawa, K Takeda, H IchijoThe Journal of biochemistry 136 (3), 261-265, 20044002004
2-) 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the …Y Hori, A Imanishi, J Matsukawa, Y Tsukimi, H Nishida, Y Arikawa, ...Journal of Pharmacology and Experimental Therapeutics 335 (1), 231-238, 20101612010
3-) Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium …Y Arikawa, H Nishida, O Kurasawa, A Hasuoka, K Hirase, N Inatomi, ...Journal of medicinal chemistry 55 (9), 4446-4456, 20121312012
4-) A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animalsY Hori, J Matsukawa, T Takeuchi, H Nishida, M Kajino, N InatomiJournal of Pharmacology and Experimental Therapeutics 337 (3), 797-804, 20111552011
5-) Potassium-competitive acid blockers: advanced therapeutic option for acid-related diseasesN Inatomi, J Matsukawa, Y Sakurai, K OtakePharmacology & therapeutics 168, 12-22, 20161352016